
Opinion|Videos|July 12, 2024
Expert Insights on NSCLC: Unmet Needs and Innovations from ASCO 2024
Jason Porter, MD, outlines the most significant unaddressed challenges in treating and managing non-small cell lung cancer as the field approaches the American Society of Clinical Oncology's 2024 annual meeting.
Advertisement
Episodes in this series

Now Playing
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Physician Peer Influence Drives Uptake of Opportunistic Salpingectomy for Ovarian Cancer Prevention
2
CAR T-Cell Therapy Holds Potential in SCLC, but Significant Barriers Remain
3
Defining the Role of Rilzabrutinib in ITP Management
4
Bispecific Antibodies in Multiple Myeloma Are Moving From Clinical Trials to Community Practice
5